RxNorm Semantic Concepts Index - 274
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "274".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 274 | Actomyosin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27403 | ifenprodil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 27403 | ifenprodil | Designated preferred name (PT) | NO | |
RxCUI: 27403 | ifenprodil | Full form of descriptor (FN) | NO | |
RxCUI: 27418 | Invariant chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27418 | Invariant chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27418 | Invariant chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27418 | Invariant chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27418 | Invariant chain | Designated preferred name (PT) | NO | |
RxCUI: 27418 | Invariant chain | Full form of descriptor (FN) | NO | |
RxCUI: 274275 | Human epididymis protein 4 | Designated preferred name (PT) | NO | |
RxCUI: 274275 | Human epididymis protein 4 | Full form of descriptor (FN) | NO | |
RxCUI: 274332 | nateglinide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 274332 | nateglinide | Designated preferred name (PT) | YES | |
RxCUI: 274332 | nateglinide | Full form of descriptor (FN) | YES | |
RxCUI: 274332 | nateglinide | Designated preferred name (PT) | YES | |
RxCUI: 274332 | nateglinide | Full form of descriptor (FN) | YES | |
RxCUI: 274342 | Etopophos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 27438 | imidazole salicylate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27438 | imidazole salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Designated preferred name (PT) | YES | |
RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Full form of descriptor (FN) | YES | |
RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Designated preferred name (PT) | YES | |
RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Full form of descriptor (FN) | YES | |
RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 27443 | Imidazoleglycerol-phosphate dehydratase | Designated preferred name (PT) | NO | |
RxCUI: 27443 | Imidazoleglycerol-phosphate dehydratase | Full form of descriptor (FN) | NO | |
RxCUI: 274534 | Inolimomab | Designated preferred name (PT) | NO | |
RxCUI: 274534 | Inolimomab | Full form of descriptor (FN) | NO | |
RxCUI: 274535 | Spiriva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 27463 | Immunoconglutinin | Designated preferred name (PT) | NO | |
RxCUI: 27463 | Immunoconglutinin | Full form of descriptor (FN) | NO | |
RxCUI: 27476 | Immunosuppressive acidic protein | Designated preferred name (PT) | NO | |
RxCUI: 27476 | Immunosuppressive acidic protein | Full form of descriptor (FN) | NO | |
RxCUI: 274771 | Nelarabine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 274771 | Nelarabine | Designated preferred name (PT) | YES | |
RxCUI: 274771 | Nelarabine | Full form of descriptor (FN) | YES | |
RxCUI: 274771 | Nelarabine | Designated preferred name (PT) | YES | |
RxCUI: 274771 | Nelarabine | Full form of descriptor (FN) | YES | |
RxCUI: 274783 | Insulin glargine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 274783 | Insulin glargine | Designated preferred name (PT) | YES | |
RxCUI: 274783 | Insulin glargine | Full form of descriptor (FN) | YES | |
RxCUI: 274783 | Insulin glargine | Designated preferred name (PT) | YES | |
RxCUI: 274783 | Insulin glargine | Full form of descriptor (FN) | YES | |
RxCUI: 274786 | telithromycin | Full form of descriptor (FN) | NO | |
RxCUI: 274786 | telithromycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 274786 | telithromycin | Designated preferred name (PT) | NO | |
RxCUI: 274786 | telithromycin | Full form of descriptor (FN) | NO | |
RxCUI: 274786 | telithromycin | Designated preferred name (PT) | NO | |
RxCUI: 27484 | Impromidine | Designated preferred name (PT) | NO | |
RxCUI: 27484 | Impromidine | Full form of descriptor (FN) | NO | |
RxCUI: 27484 | Impromidine | Designated preferred name (PT) | NO | |
RxCUI: 27484 | Impromidine | Full form of descriptor (FN) | NO | |
RxCUI: 2749 | Complement, thermolabile serum protein complex with cytotoxic effect | Designated preferred name (PT) | NO | |
RxCUI: 2749 | Complement, thermolabile serum protein complex with cytotoxic effect | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2749 | Complement, thermolabile serum protein complex with cytotoxic effect | Full form of descriptor (FN) | NO | |
RxCUI: 27492 | indanazoline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 27494 | Indanol dehydrogenase | Designated preferred name (PT) | NO | |
RxCUI: 27494 | Indanol dehydrogenase | Full form of descriptor (FN) | NO | |
RxCUI: 274961 | Zeatin O-beta-D-xylosyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 274961 | Zeatin O-beta-D-xylosyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 274964 | Ciclesonide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 274964 | Ciclesonide | Designated preferred name (PT) | YES | |
RxCUI: 274964 | Ciclesonide | Full form of descriptor (FN) | YES | |
RxCUI: 274964 | Ciclesonide | Designated preferred name (PT) | YES | |
RxCUI: 274964 | Ciclesonide | Full form of descriptor (FN) | YES | |
RxCUI: 27498 | Indecainide | Designated preferred name (PT) | NO | |
RxCUI: 27498 | Indecainide | Full form of descriptor (FN) | NO |